Guardion Health Sciences Announces 1-for-6 Reverse Stock Split Effective Pre-Market Opening on Monday, March 1, 2021GlobeNewsWire • 02/26/21
Malaysia's Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health SciencesGlobeNewsWire • 01/28/21
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price RuleGlobeNewsWire • 01/27/21
Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive OfficerGlobeNewsWire • 12/28/20
Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-VGlobeNewsWire • 12/16/20
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2020GlobeNewsWire • 11/12/20
Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardion's Proprietary Lumega-Z® Formulation Compared to AREDS-2 FormulationGlobeNewsWire • 10/28/20
Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders' MeetingGlobeNewsWire • 10/27/20
Guardion Health Sciences Announces Investigator-Initiated Clinical Trial of Lumega-ZGlobeNewsWire • 10/26/20
Guardion Health Sciences Product Licensee Receives Registration Approval in Malaysia for Immune Support SupplementGlobeNewsWire • 08/27/20
Guardion Health Sciences Adds Experienced Vice President and Chief Financial Officer to Executive Management TeamGlobeNewsWire • 07/21/20
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 TrademarkGlobeNewsWire • 07/15/20
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye DiseaseGlobeNewsWire • 07/08/20
Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate CustomerGlobeNewsWire • 06/30/20
Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive OfficerGlobeNewsWire • 06/15/20